Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Bioteknik |
As previously announced, the Extraordinary General Meeting of Hamlet Pharma held on the 4[th ]of March, elected Professor Bill Hansson to the board of Hamlet Pharma.
Bill Hansson was until recently Vice President of the Max Planck Society. In this capacity he facilitated the progress of science in Germany and internationally and during his leadership, the organization has flourished, as illustrated e.g. by the recent Nobel Prize awards. Bill Hansson has also overseen the translation of scientific innovations for public and commercial use and spearheaded a new human resources and communication strategy for the MPS. Bill Hansson is an internationally recognized scientist in the field of biology and his extensive academic leadership includes his present directorship at the Max Planck Institute for Chemical Ecology in Jena. Bill Hansson was recently awarded the Federal Cross of Merit 1[st] Class by the President of Germany.
Hamlet Pharma would also like to thank Rolf Carlsson for his role on the board of directors.
Rolf Carlsson was elected to the board at the AGM in November 2019 and has contributed to the development of the company. Rolf Carlsson is running a successful head hunting business, which now is expanding, and he will focus on this task. Rolf Carlsson's experience of life science has stimulated discussions about the vision and strategy of the company. We thank him for his contributions.